Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men
Titel:
Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men
Auteur:
Carballo-Diéguez, Alex Giguere, Rebecca Dolezal, Curtis Leu, Cheng-Shiun Balán, Iván C. Brown, William Rael, Christine Richardson, Barbra A. Piper, Jeanna M. Bekker, Linda-Gail Chariyalertsak, Suwat Chitwarakorn, Anupong Gonzales, Pedro Holtz, Timothy H. Liu, Albert Mayer, Kenneth H. Zorrilla, Carmen D. Lama, Javier R. McGowan, Ian Cranston, Ross D.